Literature DB >> 17347801

Rho kinase in the regulation of cell death and survival.

Jianjian Shi1, Lei Wei.   

Abstract

Rho kinase (ROCK) belongs to a family of serine/threonine kinases that are activated via interaction with Rho GTPases. ROCK is involved in a wide range of fundamental cellular functions, such as contraction, adhesion, migration, and proliferation. Recent studies have shown that ROCK plays an important role in the regulation of apoptosis in various cell types and animal disease models. Two ROCK isoforms, ROCK1 and ROCK2, are assumed to be function redundant, this based largely on kinase construct overexpression and chemical inhibitors (Y27632 and fasudil) which inhibit both ROCK1 and ROCK2. Gene targeting and RNA interference approaches allow further dissection of distinct cellular, physiological, and patho-physiological functions of the two ROCK isoforms. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of ROCK signaling in the regulation of apoptosis and highlights new findings from recently generated ROCK-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17347801      PMCID: PMC2612781          DOI: 10.1007/s00005-007-0009-7

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  155 in total

1.  Identification of calponin as a novel substrate of Rho-kinase.

Authors:  T Kaneko; M Amano; A Maeda; H Goto; K Takahashi; M Ito; K Kaibuchi
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

2.  The RhoA/ROCK-I/MLC pathway is involved in the ethanol-induced apoptosis by anoikis in astrocytes.

Authors:  Rebeca Miñambres; Rosa M Guasch; Amparo Perez-Aragó; Consuelo Guerri
Journal:  J Cell Sci       Date:  2006-01-03       Impact factor: 5.285

3.  Rho kinase regulates fragmentation and phagocytosis of apoptotic cells.

Authors:  Kelly A Orlando; Nicole L Stone; Randall N Pittman
Journal:  Exp Cell Res       Date:  2005-11-02       Impact factor: 3.905

4.  ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis.

Authors:  Georgia Mavria; Yvonne Vercoulen; Maggie Yeo; Hugh Paterson; Maria Karasarides; Richard Marais; Demelza Bird; Christopher J Marshall
Journal:  Cancer Cell       Date:  2006-01       Impact factor: 31.743

5.  Raf-1 sets the threshold of Fas sensitivity by modulating Rok-alpha signaling.

Authors:  Daniela Piazzolla; Katrin Meissl; Lucia Kucerova; Cristina Rubiolo; Manuela Baccarini
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

6.  Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.

Authors:  T Ishizaki; M Uehata; I Tamechika; J Keel; K Nonomura; M Maekawa; S Narumiya
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

7.  Agonists trigger G protein-mediated activation of the CPI-17 inhibitor phosphoprotein of myosin light chain phosphatase to enhance vascular smooth muscle contractility.

Authors:  T Kitazawa; M Eto; T P Woodsome; D L Brautigan
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

8.  Rho/ROCK pathway as a target of tumor therapy.

Authors:  R Rattan; S Giri; A K Singh; I Singh
Journal:  J Neurosci Res       Date:  2006-02-01       Impact factor: 4.164

Review 9.  Physiological role of ROCKs in the cardiovascular system.

Authors:  Kensuke Noma; Naotsugu Oyama; James K Liao
Journal:  Am J Physiol Cell Physiol       Date:  2006-03       Impact factor: 4.249

10.  Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP.

Authors:  Malia B Potts; Allyson E Vaughn; Holly McDonough; Cam Patterson; Mohanish Deshmukh
Journal:  J Cell Biol       Date:  2005-12-12       Impact factor: 10.539

View more
  94 in total

1.  The effect of Rho kinase inhibitor Y-27632 on endotoxemia-induced intestinal apoptosis in infant rats.

Authors:  Durgul Ozdemir; Serap Cilaker; Kazim Tugyan; Mustafa Kemal Dagdelen; Oksan Derinoz; Ensari Guneli
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

2.  Inhibition of planar cell polarity extends neural growth during regeneration, homeostasis, and development.

Authors:  Wendy S Beane; Ai-Sun Tseng; Junji Morokuma; Joan M Lemire; Michael Levin
Journal:  Stem Cells Dev       Date:  2012-03-23       Impact factor: 3.272

3.  ROCK inhibitor Y-27632 increases thaw-survival rates and preserves stemness and differentiation potential of human Wharton's jelly stem cells after cryopreservation.

Authors:  Kalamegam Gauthaman; Chui-Yee Fong; Arjunan Subramanian; Arijit Biswas; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

4.  Cathepsin B and phospo-JNK in relation to ongoing apoptosis after transient focal cerebral ischemia in the rat.

Authors:  Zhi Bo Zhang; Zhi Gang Li
Journal:  Neurochem Res       Date:  2012-01-22       Impact factor: 3.996

5.  Pharmacological inhibition of Rho-kinase (ROCK) signaling enhances cisplatin resistance in neuroblastoma cells.

Authors:  Catharine A Street; Alissa A Routhier; Carrie Spencer; Ashley L Perkins; Katherine Masterjohn; Alexander Hackathorn; John Montalvo; Emily A Dennstedt; Brad A Bryan
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

Review 6.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 7.  Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.

Authors:  Jing-bin Huang; Ying-long Liu; Pei-wu Sun; Xiao-dong Lv; Kong Bo; Xiang-ming Fan
Journal:  Lung       Date:  2010-03-06       Impact factor: 2.584

Review 8.  Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Authors:  Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami
Journal:  Pharmacol Ther       Date:  2014-02-26       Impact factor: 12.310

9.  Downregulation of ROCK-I and ROCK-II gene expression in the cadmium-induced ventral body wall defect chick model.

Authors:  Takashi Doi; Prem Puri; John Bannigan; Jennifer Thompson
Journal:  Pediatr Surg Int       Date:  2008-12       Impact factor: 1.827

10.  Presence of a ROCK inhibitor in extracellular matrix supports more undifferentiated growth of feeder-free human embryonic and induced pluripotent stem cells upon passaging.

Authors:  Mohammad Pakzad; Mehdi Totonchi; Adeleh Taei; Ali Seifinejad; Seyedeh Nafiseh Hassani; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.